// COMPANY
GordonMD Global Investments
SECTOR VENTURE CAPITALMENTIONS 1LAST SEEN JUNE 24, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·PitchBook News·JUNE 24, 2026
“Rapalogix Health: Biotech specializing in cellular longevity in dermatology. Secured a $20 million Series A led by GordonMD Global Investments and Woodline Partners.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.